RNA Analytical/Quality Videos
-
Real-Time Protein Titer Measurements: Simple, Automated, And Compact Solution
7/3/2025
Accelerate your workflow with an automated IgG titer solution. Obtain precise results quickly, enhancing efficiency from process development to manufacturing.
-
Streamline Your mRNA Purification Steps
3/4/2025
Ensure your mRNA's stability and effectiveness post-transcription with advanced filtration and chromatography techniques to enhance purity and recovery, which delivers high-quality mRNA for superior therapeutics and vaccines.
-
3 Must-Improve Areas in mRNA Process Development
10/15/2025
In this Advancing RNA Live clip, panelists Stu Sundseth, Marc Wolfgang, and Christian Dohmen each provide their take on the most critical areas for improvement in mRNA process development.
-
Which mRNA-LNP Attributes Deserve Deeper Characterization Today?
6/9/2026
This Advancing RNA Live panel comprising Elaine Peters, Ilya Shestopalov, and Philippe Talaga addresses which mRNA-LNP attributes could benefit the most from orthogonal extended characterization.
-
mRNA/saRNA Manufacturing: Accelerate The Path To Clinic
3/22/2021
Discover key upstream and downstream considerations for process development for RNA drug substance manufacturing and the parameters that need construct-specific optimization to increase yield and reduce impurities.
-
Robust And Cost-Effective mRNA Capping
12/8/2025
Master the essential strategies for cost-effective and robust mRNA capping at industrial scale. Learn how to successfully evaluate new materials and optimize your synthesis process for maximum efficiency and yield.
-
Analytical Limitations In Assessing Plasmid Quality for mRNA Production
4/11/2025
There remain a lot of gaps in our understanding of plasmid quality, particularly for high-quality mRNA production (as opposed to viral vector production). In this segment of a recent Advancing RNA Live panel, speakers Adi Nair, Tyler Goodwin, and April Sena highlight their biggest questions around plasmid DNA quality, as well as the pros and cons of some of the analytical methods upon which we’re relying most heavily today to assess plasmid quality.
-
The Make-or-Break Quality Attributes of Plasmid DNA
10/15/2025
We all know that plasmid quality is foundational in dictating the quality of the final mRNA drug substance. In this clip homing in on upstream process considerations, speakers Stu Sundseth (Tune Therapeutics), Marc Wolfgang (Sail Biomedicines), and Christian Dohmen (Ethris) outline some of the most important CQAs for plasmids and the impact they can have on the resulting quality of the mRNA drug substance for linear mRNA.
-
Development Of A Mitra Tip Extraction Assay Coupled With LC-MSMS
1/15/2025
Watch this rundown of a novel method for quantifying L-Citrulline, L-Arginine, and L-Argininosuccinic acid using Mitra tip extraction coupled with LC-MS/MS for enhanced accuracy and reproducibility.
-
The Pre-IND "Diaries": What Can mRNA Makers Expect From Early FDA Engagement?
5/10/2024
Nutcracker Therapeutics’ Oreanna Thomas shares her takeaways from a pre-IND meeting for one of the company’s mRNA therapeutic candidates.